Background: Primary angle closure glaucoma (PACG) is a leading cause of bilateral blindness worldwide. Laser peripheral iridotomy (LPI) has been proposed as the standard prophylactic option for patients with the risk of developing the spectrum of disease, from primary angle closure suspect (PACS) toprimary angle closure (PAC) then to PACG. We aim to evaluate the effect of LPI on intraocular pressure(IOP), anterior chamber depth (ACD) and angle width, as prophylactic management in PACS and PAC.Methods: Literature search was conducted from MEDLINE database using Pubmed search engine.Inclusion criteria were all studies (interventional and observational) that reported outcomes of LPI onPACS and/or PAC eyes. Exclusion criteria were outcomes of LPI on PACG eyes.Results: There were 8 studies included in this literature review; 4 studies evaluated patients with PACS,1 study evaluated patients with PAC, while 3 studies had compared between PACS and PAC. FollowingLPI, majority of the studies showed a decrease of IOP when compared to baseline. While, 5 studiesevaluated changes of central ACD and majority of those studies indicated deepening of ACD. Fourstudies had assessed the angle width changes after LPI that revealed advancement of angle width.Conclusion: The results of this literature review showed that LPI in PACS and PAC eyes showed decrease of IOP within a specified period, the deepening of central ACD and increase of angle width.Keywords: Primary angle closure suspect, primary angle closure, laser peripheral iridotomy
In the past decades, indications for PPV in paediatric patients has been rising with large heterogeneity outcomes among studies. Our objective is to present a pilot descriptive study in Indonesia, regarding pars plana vitrectomy (PPV) success rate in paediatric patients with rhegmatogenous retinal detachment (RRD) in Dr. Cipto Mangunkusumo Hospital (CMH). A retrospective study was conducted on 16 paediatric eyes diagnosed for RRD and treated in CMH during the period of January 2017 to December 2017. A total of 16 RRD eyes were identified in 15 individuals. Majority of the patients were male and were in the age group of 12-18 years. There were 13 patients undergone PPV with or without SB. Functional anatomical success rate was determined from the macula status while functional success rate on final BCVA. Among 16 patients, 14 had constant or increased final BCVA and 11 had reattached macula. The success rate of PPV in terms of anatomical outcome was 11 out of 16 eyes and in functional outcome was 8 out of 16 eyes. Keywords: pars plana vitrectomy, paediatric ophthalmology, rhegmatogenous retinal detachment. Karakteristik dan Hasil Vitrektomi Pars Plana pada Pasien Pediatrik di Divisi Vitreoretina Rumah Sakit Cipto Mangunkusumo Tahun 2017 Abstrak Indikasi tindakan vitrektomi pars plana (PPV) pada pasien pediatrik bertambah secara signifikan dalam beberapa dekade terakhir. Penelitian ini dilakukan sebagai studi awal di Indonesia, terkait tingkat keberhasilan PPV pada pasien anak dengan rhegmatogenous retinal detachment (RRD) khususnya di RS Cipto Mangunkusumo (RSCM). Studi retrospektif dilakukan terhadap 16 mata RRD pada 15 pasien anak di RSCM pada periode Januari 2017 – Desember 2017. Mayoritas pasien merupakan laki-laki dalam kelompok umur 12-18 tahun. Terdapat 13 pasien yang menjalani PPV dengan atau tanpa scleral buckle (SB). Tingkat keberhasilan anatomi dilihat dari status penempelan makula, sementara tingkat keberhasilan fungsional dinilai dari visus akhir. Tingkat keberhasilan anatomi PPV dalam studi ini adalah 11/16 mata, dan tingkat keberhasilan fungsional mencapai 8/16 mata. Kata kunci: vitrektomi pars plana, oftalmologi pediatrik, rhegmatogenous retinal detachment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.